NORATIS AG(FRA:NUVA) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to NUVA. NUVA was compared to 69 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of NUVA have multiple concerns. While showing a medium growth rate, NUVA is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NUVA has reported negative net income.

In the past year NUVA had a positive cash flow from operations.

NUVA had positive earnings in 4 of the past 5 years.

In the past 5 years NUVA reported 4 times negative operating cash flow.

1.2 Ratios

NUVA's Return On Assets of -6.08% is on the low side compared to the rest of the industry. NUVA is outperformed by 64.00% of its industry peers.

NUVA's Return On Equity of -42.03% is on the low side compared to the rest of the industry. NUVA is outperformed by 70.67% of its industry peers.

The Return On Invested Capital of NUVA (1.00%) is comparable to the rest of the industry.

NUVA had an Average Return On Invested Capital over the past 3 years of 2.51%. This is in line with the industry average of 4.12%.

		Industry Rank	Sector Rank
ROA	-6.08%
ROE	-42.03%
ROIC	1%

ROA(3y)0.49%

ROA(5y)1.08%

ROE(3y)2.81%

ROE(5y)5.59%

ROIC(3y)2.51%

ROIC(5y)2.76%

1.3 Margins

With a decent Operating Margin value of 12.12%, NUVA is doing good in the industry, outperforming 64.00% of the companies in the same industry.

In the last couple of years the Operating Margin of NUVA has declined.

NUVA has a Gross Margin (33.21%) which is in line with its industry peers.

NUVA's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	12.12%
PM (TTM)	N/A
GM	33.21%

OM growth 3Y-12.49%

OM growth 5Y-25.35%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-15.23%

GM growth 5Y-19.43%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUVA is destroying value.

NUVA has more shares outstanding than it did 1 year ago.

The number of shares outstanding for NUVA has been increased compared to 5 years ago.

The debt/assets ratio for NUVA has remained at the same level compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.35, we must say that NUVA is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of NUVA (1.35) is better than 82.67% of its industry peers.

NUVA has a debt to FCF ratio of 25.77. This is a negative value and a sign of low solvency as NUVA would need 25.77 years to pay back of all of its debts.

NUVA has a better Debt to FCF ratio (25.77) than 68.00% of its industry peers.

NUVA has a Debt/Equity ratio of 5.06. This is a high value indicating a heavy dependency on external financing.

NUVA's Debt to Equity ratio of 5.06 is on the low side compared to the rest of the industry. NUVA is outperformed by 77.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	5.06
Debt/FCF	25.77
Altman-Z	1.35

ROIC/WACC0.3

WACC3.39%

2.3 Liquidity

A Current Ratio of 7.75 indicates that NUVA has no problem at all paying its short term obligations.

The Current ratio of NUVA (7.75) is better than 93.33% of its industry peers.

A Quick Ratio of 0.34 indicates that NUVA may have some problems paying its short term obligations.

The Quick ratio of NUVA (0.34) is worse than 64.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	7.75
Quick Ratio	0.34

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NUVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -628.53%.

NUVA shows a decrease in Revenue. In the last year, the revenue decreased by -6.90%.

Measured over the past years, NUVA shows a small growth in Revenue. The Revenue has been growing by 1.41% on average per year.

EPS 1Y (TTM)-628.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-321.33%

Revenue 1Y (TTM)-6.9%

Revenue growth 3Y27.99%

Revenue growth 5Y1.41%

Sales Q2Q%-38.01%

3.2 Future

Based on estimates for the next years, NUVA will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.72% on average per year.

NUVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.63% yearly.

EPS Next Y-154.43%

EPS Next 2Y26.68%

EPS Next 3Y24.72%

EPS Next 5Y16.72%

Revenue Next Year-2.16%

Revenue Next 2Y37.08%

Revenue Next 3Y30.59%

Revenue Next 5Y15.63%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NUVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NUVA. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NUVA indicates a somewhat cheap valuation: NUVA is cheaper than 61.33% of the companies listed in the same industry.

Based on the Price/Free Cash Flow ratio, NUVA is valued cheaper than 98.67% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	1.13
EV/EBITDA	61.43

4.3 Compensation for Growth

NUVA's earnings are expected to grow with 24.72% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y26.68%

EPS Next 3Y24.72%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NUVA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NORATIS AG

FRA:NUVA (3/7/2025, 7:00:00 PM)

1.24

-0.16 (-11.43%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryReal Estate Management & Development

Earnings (Last)N/A N/A

Earnings (Next)05-25 2025-05-25/amc

Inst Owners0.58%

Inst Owner ChangeN/A

Ins Owners2.11%

Ins Owner ChangeN/A

Market Cap16.83M

Analysts40

Price Target1.09 (-12.1%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-2.52%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-30.43%

EPS NY rev (3m)-2.68%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0.86%

Revenue NY rev (3m)0.86%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.35
P/FCF	1.13
P/OCF	1.13
P/B	0.26
P/tB	0.26
EV/EBITDA	61.43

EPS(TTM)-4.25

EYN/A

EPS(NY)-0.66

Fwd EYN/A

FCF(TTM)1.09

FCFY88.16%

OCF(TTM)1.09

OCFY88.25%

SpS3.5

BVpS4.82

TBVpS4.82

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.08%
ROE	-42.03%
ROCE	1.45%
ROIC	1%
ROICexc	1.03%
ROICexgc	1.03%
OM	12.12%
PM (TTM)	N/A
GM	33.21%
FCFM	31.26%

ROA(3y)0.49%

ROA(5y)1.08%

ROE(3y)2.81%

ROE(5y)5.59%

ROIC(3y)2.51%

ROIC(5y)2.76%

ROICexc(3y)2.58%

ROICexc(5y)2.87%

ROICexgc(3y)2.58%

ROICexgc(5y)2.87%

ROCE(3y)3.63%

ROCE(5y)4%

ROICexcg growth 3Y3.42%

ROICexcg growth 5Y-34.46%

ROICexc growth 3Y3.42%

ROICexc growth 5Y-34.46%

OM growth 3Y-12.49%

OM growth 5Y-25.35%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-15.23%

GM growth 5Y-19.43%

F-Score3

Asset Turnover0.11

Health

		Industry Rank	Sector Rank
Debt/Equity	5.06
Debt/FCF	25.77
Debt/EBITDA	52.51
Cap/Depr	2.76%
Cap/Sales	0.03%
Interest Coverage	0.31
Cash Conversion	235.94%
Profit Quality	N/A
Current Ratio	7.75
Quick Ratio	0.34
Altman-Z	1.35

F-Score3

WACC3.39%

ROIC/WACC0.3

Cap/Depr(3y)21.85%

Cap/Depr(5y)22.27%

Cap/Sales(3y)0.13%

Cap/Sales(5y)0.16%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-628.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-321.33%

EPS Next Y-154.43%

EPS Next 2Y26.68%

EPS Next 3Y24.72%

EPS Next 5Y16.72%

Revenue 1Y (TTM)-6.9%

Revenue growth 3Y27.99%

Revenue growth 5Y1.41%

Sales Q2Q%-38.01%

Revenue Next Year-2.16%

Revenue Next 2Y37.08%

Revenue Next 3Y30.59%

Revenue Next 5Y15.63%

EBIT growth 1Y-39.66%

EBIT growth 3Y12.01%

EBIT growth 5Y-24.3%

EBIT Next Year-291.42%

EBIT Next 3Y32.54%

EBIT Next 5Y25.94%

FCF growth 1Y134.63%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y134.74%

OCF growth 3YN/A

OCF growth 5YN/A

NORATIS AG (NUVA.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens